Corvus Pharmaceuticals CRVS
NASDAQ CRVS
$10.53 -0.12 (-1.13%)
At close: Oct 23, 2026 · 4:00 PM EDT

Corvus Pharmaceuticals (CRVS) Sale and Maturity of Investments (2015 - 2026)

Updated

Analysis

Corvus Pharmaceuticals (CRVS) Sale and Maturity of Investments (2015 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Corvus Pharmaceuticals 885.79 Mn 374.23 Mn - 47.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 47.36 Mn
Mar 31, 2026 16.98 Mn
Dec 31, 2025 24.32 Mn
Sep 30, 2025 28.53 Mn
Jun 30, 2025 19.29 Mn
Mar 31, 2025 11.99 Mn
Dec 31, 2024 14.27 Mn
Sep 30, 2024 14.95 Mn
Jun 30, 2024 8.79 Mn
Mar 31, 2024 4.62 Mn
Dec 31, 2023 9.11 Mn
Sep 30, 2023 19.36 Mn
Jun 30, 2023 16.43 Mn
Mar 31, 2023 17.73 Mn
Dec 31, 2022 15.40 Mn
Sep 30, 2022 20.78 Mn
Jun 30, 2022 6.18 Mn
Mar 31, 2022 810,000.00
Dec 31, 2021 2.50 Mn
Sep 30, 2021 3.63 Mn
API Access

Corvus Pharmaceuticals Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=CRVS&period=max&api_key=YOUR_API_KEY